 |
The Journal of Neuroscience, December 3, 2003, 23(35):11224-11228
Previous Article | Next Article 
Cellular/Molecular
Angiotensin II Blocks Nicotine-Mediated Neuroprotection against -Amyloid (1-42) via Activation of the Tyrosine Phosphatase SHP-1
Seán Shaw,1
Merouane Bencherif,3 and
Mario B. Marrero1,2
1Vascular Biology Center and 2Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta, Georgia 30912, and 3Targacept Inc., Winston-Salem, North Carolina 27101-4165
We showed recently that nicotine activates the growth-promoting enzyme Janus kinase 2 (JAK2) in PC12 cells and that preincubation of these cells with the JAK2-specific inhibitor AG-490 blocked the nicotine-induced neuroprotection against -amyloid (1-42) [A (1-42)]. These results provided direct evidence for linkage between JAK2 and the 7 nicotinic acetylcholine receptor-induced neuroprotection in PC12 cells. We also showed that preincubation with angiotensin II (Ang II), functioning via the angiotensin II type 2 (AT2) receptor, blocked both the nicotine-induced activation of JAK2 and its neuroprotection against A (1-42). Recently growth-inhibitory effects of the AT2 receptor have been reported to be mediated by the activation of protein tyrosine phosphatases (PTPases) and that AT2 receptor stimulation is associated with a rapid activation of the PTPase SHP-1 (the cytoplasmic tyrosine phosphatase that contains Src homology 2 domains), a negative regulator of JAK2 signaling. Therefore, the potential biological significance of AT2 receptor-induced effects on both the nicotine-induced activation of JAK2 and its neuroprotection against A (1-42) led us to investigate whether SHP-1 activation could be involved in this process. We found that Ang II induced the activation of SHP-1 and that an antisense against SHP-1 not only augmented the nicotine-induced tyrosine phosphorylation of JAK2 but also blocked the Ang II neutralization of the nicotine-induced neuroprotection. These results demonstrate that nicotine-induced tyrosine phosphorylation of JAK2 and neuroprotection against A (1-42) in PC12 cells are blocked by Ang II via AT2 receptor-induced activation of SHP-1.
Key words: nicotine; neuroprotection; JAK2; phosphatydylinositol-3-kinase; SHP-1; PC12 cells; Alzheimer's disease; Ang II
Received April 16, 2003;
revised October 7, 2003;
accepted October 10, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
M. C. Zatelli, D. Piccin, F. Tagliati, A. Bottoni, A. Luchin, and E. C. degli Uberti
Src Homology-2-Containing Protein Tyrosine Phosphatase-1 Restrains Cell Proliferation in Human Medullary Thyroid Carcinoma
Endocrinology,
June 1, 2005;
146(6):
2692 - 2698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Stumm, C. Zhou, S. Schulz, M. Endres, G. Kronenberg, J. P. Allen, G. Tulipano, and V. Hollt
Somatostatin Receptor 2 Is Activated in Cortical Neurons and Contributes to Neurodegeneration after Focal Ischemia
J. Neurosci.,
December 15, 2004;
24(50):
11404 - 11415.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|